Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.

Corcept Therapeutics shares nearly doubled in premarket trading Monday after the company said it received positive data from its phase 3 ovarian cancer treatment trial. Shares rose 93% ahead of the ...

Corcept Therapeutics said on Monday its experimental combination ovarian cancer drug improved survival in patients with a ...

The new study in animal models will investigate whether "initiated” cells, harboring a mutant RAS oncogene, can be eliminated ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

With a new key hire, the Napster cofounder’s cancer fighting non-profit is ready to back the science both governments and ...

Corcept Therapeutics said on Monday its experimental ovarian cancer drug in combination with chemotherapy met the main goal of a late-stage trial.

A grieving woman from Ipswich hopes that a new law will create changes in the NHS, after her mum died from a misdiagnosed cancer.

Ovarian cancer—known as a silent killer due to its inability to showcase most of its symptoms—kills many women every year ...

A grieving daughter is campaigning for a new law requiring mandatory second opinions on benign cancer diagnoses within the ...

Earlier this week, Brosnan and his rarely-seen granddaughter Isabella Smith arrived at the MobLand premiere afterparty. In ...

Investigators at Mass General Brigham have uncovered how resistance to chemotherapies may occur in some cancers. Researchers ...